VJOncology is committed to improving our service to you

ELCC 2019 | A STELLAR study: TTFields for malignant pleural mesothelioma

VJOncology is committed to improving our service to you

Ori Farber

In this interview, Ori Farber, MD, of Novocure, Haifa, Israel, discusses the promising results of the STELLAR study (NCT02397928) utilizing tumor treating fields (TTF) for the treatment of malignant pleural mesothelioma. This video was recorded at the European Lung Cancer Congress (ELCC) 2019, held in Geneva, Switzerland.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter